Atlas Trials

Neuroprotection With Riluzole Patients With Early Multiple Sclerosis

Clinical trial NCT00501943 · COMPLETED

Trial details

NCT number
NCT00501943
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2006-07-01
Primary completion
2012-10-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.